Operating loss increased with decreased sales and increased investment expenses. Ordinary and net loss sharply increased with non-operating expenses sharply increased by loss from equity share valuation, bad check write-off and revaluation of long-term investment securities. Bio business was added to business purpose while acquiring new subsidiary Hurim Bio Cell that conducts stem cell, medicine and pharmaceutical research and development. Plans to strengthen new business lines like bio and robot business with Hurim Bio Cell and Ki-Robot acquired last year. Financial structure will become somewhat unstable with rising debt dependence and liability ratio as short-term borrowings increased. Liability increased with rights issue and bonds while sales cash flow remains in minus with growing prepaid expenses.
Headquarters
RM.1206, C-DONG, BUPYEONG WOOLIM LIONS VALLEY, 425, CHEONGCHEON 2-DONG, BUPYEONG-GU, INCHEON
Incheon; Incheon;
Postal Code: 429848
Contact Details: Purchase the Apro Technology Co., Ltd. report to view the information.
Website: http://www.aprocctv.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service